Zelira Therapeutics Ltd.ASX: ZLD

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Zelira Therapeutics Ltd. via ASX

Filed with ASX ·

ASX ANNOUNCEMENT 30 October 2026 QUARTERLY ACTIVITIES REPORT FOR Q1 FY2027 ASX ANNOUNCEMENT Key Highlights Transformative US$33M Fundraising into Zelira’s HOPE® 1 SPV ® • Zelira’s HOPE 1 SPV signed definitive agreements to raise US$32,981,075 (before costs), announced 16 January ® • On a...

View Attachment

6ix is reading this filing.

Zelira Therapeutics Ltd. on 6ix

Story so far

Earlier from Zelira Therapeutics

All Zelira Therapeutics news releases